Yonsa 1
Yonsa Tablet
Product Images NDC 47335-401
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Yonsa (NDC 47335-401). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Yonsa 2
The text appears to be a table showing the results of a study or experiment involving a drug called Abiraterone Acetate and a placebo. The table shows the number of months until death for two groups, one receiving the drug and one receiving a placebo. The results appear to be categorized into four sections, with headings "797," "398," "H < L3 L]," and "Time to death, months." Without more contextual information, it is difficult to determine the purpose or significance of the study.*
Yonsa 3
Yonsa 4
Yonsa 5
Yonsa is a prescription medication containing 125 mg of abiraterone acetate. It is important to note that this medication may have different dosing and food effects than other abiraterone acetate products. The package insert should be consulted for dosing information. The tablets should be swallowed whole and not crushed, chewed, or dissolved. Yonsa is manufactured for Sun Pharma Global FZE and distributed by Sun Pharmace in Cranbury, NJ. It should be stored at 15°C to 30°C (SF to BE°F) and kept out of reach of children. This information is current as of February 2021, and the NDC number is 47335-401-81.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
